ciglitazone has been researched along with transforming growth factor beta in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capron, M; Dombrowicz, D; Honda, K; Marquillies, P | 1 |
| Burgess, HA; Daugherty, LE; Lakatos, HF; Phipps, RP; Ray, DM; Redonnet, M; Sime, PJ; Thatcher, TH | 1 |
| Chen, N; Liu, F; Wang, WM | 1 |
| Carson, WE; Lesinski, GB; Nye, KJ; VanBuskirk, AM; Yee, LD | 1 |
| Makino, H; Ogawa, D; Ohga, S; Okada, S; Shikata, K; Shikata, Y; Usui, H; Wada, J; Yozai, K | 1 |
| Fu, WM; Lin, CP; Lin, TH; Tang, CH; Yang, RS | 1 |
6 other study(ies) available for ciglitazone and transforming growth factor beta
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Female; Immunohistochemistry; Lung; Mice; Mice, Inbred BALB C; Nebulizers and Vaporizers; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Trachea; Transcription Factors; Transforming Growth Factor beta | 2004 |
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Topics: Actins; Anilides; Cell Differentiation; Collagen Type I; Fibroblasts; Humans; Hypoglycemic Agents; Lung; Muscle, Smooth; PPAR gamma; Prostaglandin D2; Pulmonary Fibrosis; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2005 |
[Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Topics: Animals; Blotting, Far-Western; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Kidney; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
TGF-beta inhibition of CTL re-stimulation requires accessory cells and induces peroxisome-proliferator-activated receptor-gamma (PPAR-gamma).
Topics: Antigen-Presenting Cells; Cell Line; Gene Expression Regulation; Herpesvirus 4, Human; Humans; Hypersensitivity, Delayed; Immunologic Memory; Interferon-gamma; PPAR gamma; T-Lymphocytes, Cytotoxic; Thiazolidinediones; Transforming Growth Factor beta | 2006 |
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Macrophage Activation; Male; NF-kappa B; Pioglitazone; PPAR gamma; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thiocarbamates; Transforming Growth Factor beta | 2007 |
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
Topics: Aging; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation, Enzymologic; Ligands; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoblasts; Osteogenesis; PPAR gamma; Prostaglandin D2; Rats; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transforming Growth Factor beta | 2007 |